Yüce, M. Et Al. 2021. Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS , vol.89, no.11 , 1425-1441.

Yüce, M., Çiçek, E., Inan, T., Dag, A. B., Kurkcuoglu, O., & Sungur, F. A., (2021). Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS , vol.89, no.11, 1425-1441.

Yüce, Merve Et Al. "Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease," PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS , vol.89, no.11, 1425-1441, 2021

Yüce, Merve Et Al. "Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease." PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS , vol.89, no.11, pp.1425-1441, 2021

Yüce, M. Et Al. (2021) . "Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease." PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS , vol.89, no.11, pp.1425-1441.

@article{article, author={Merve Yüce Et Al. }, title={Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease}, journal={PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS}, year=2021, pages={1425-1441} }